Table 4 Cost-utility analysis for healthcare costs and societal or total costs in euros with discount (3%) and disaggregated by gender and socioeconomic status by the duration of the intervention effect
From: Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
Discount (3%) | Base case | UPRIGHT | ∆ Cost | ∆ QALY | ICUR | ||
Healthcare costs | Cost (€) | QALY | Cost (€) | QALY | |||
Total (2 years) | 4,059 | 10.81 | 4,112 | 10.82 | 53.64 | 0.02 | 3,231 |
Low SES male | 5,430 | 10.72 | 5,421 | 10.73 | -8.41 | 0.01 | Dominant |
High SES male | 3,974 | 10.87 | 4,053 | 10.88 | 78.83 | 0.01 | 8,744 |
Low SES female | 4,969 | 10.66 | 4,929 | 10.69 | -39.80 | 0.02 | Dominant |
High SES female | 3,951 | 10.77 | 3,994 | 10.79 | 42.58 | 0.02 | 1,815 |
Total (5 years) | 4,059 | 10.81 | 4,098 | 10.83 | 39.84 | 0.02 | 1,939 |
Low SES male | 5,430 | 10.72 | 5,386 | 10.74 | -43.83 | 0.02 | Dominant |
High SES male | 3,974 | 10.87 | 4,038 | 10.88 | 63.95 | 0.01 | 5,492 |
Low SES female | 4,969 | 10.66 | 4,894 | 10.69 | -74.64 | 0.03 | Dominant |
High SES female | 3,951 | 10.77 | 3,984 | 10.79 | 33.30 | 0.03 | 1,176 |
Total Systematic Review [27] | 4,059 | 10.81 | 4.129 | 10.82 | 70 | 0.01 | 5,440 |
Low SES male | 5,430 | 10.72 | 5.470 | 10.73 | 40 | 0.01 | 5,178 |
High SES male | 3,974 | 10.87 | 4.073 | 10.88 | 99 | 0.01 | 17,201 |
Low SES female | 4,969 | 10.66 | 4.961 | 10.68 | -8 | 0.02 | Dominant |
High SES female | 3,951 | 10.77 | 4.003 | 10.79 | 52 | 0.02 | 2,651 |
Discount (3%) | Base case | UPRIGHT | ∆ Cost | ∆ QALY | ICUR | ||
Societal costs | Cost (€) | QALY | Cost (€) | QALY | |||
Total (2 years) | 12,757 | 10.81 | 12,643 | 10.82 | -114 | 0.02 | Dominant |
Low SES male | 28,256 | 10.72 | 27,933 | 10.73 | -323 | 0.01 | Dominant |
High SES male | 13,337 | 10.87 | 13,269 | 10.88 | -68 | 0.01 | Dominant |
Low SES female | 18,402 | 10.66 | 18,049 | 10.69 | -353 | 0.02 | Dominant |
High SES female | 10,467 | 10.77 | 10,347 | 10.79 | -120 | 0.02 | Dominant |
Total (5 years) | 12,757 | 10.81 | 12,558 | 10.83 | -199 | 0.02 | Dominant |
Low SES male | 28,256 | 10.72 | 27,798 | 10.74 | -458 | 0.02 | Dominant |
High SES male | 13,337 | 10.87 | 13,205 | 10.88 | -132 | 0.01 | Dominant |
Low SES female | 18,402 | 10.66 | 17,857 | 10.69 | -545 | 0.03 | Dominant |
High SES female | 10,467 | 10.77 | 10,255 | 10.79 | -212 | 0.03 | Dominant |
Total Systematic Review [28] | 12,757 | 10.81 | 12,722.80 | 10.82 | -34.00 | 0.01 | Dominant |
Low SES male | 28,256 | 10.72 | 28,103 | 10.73 | -153 | 0.01 | Dominant |
High SES male | 13,337 | 10.87 | 13,352 | 10.88 | 15 | 0.01 | 2,606 |
Low SES female | 18,402 | 10.66 | 18,183 | 10.68 | -219 | 0.02 | Dominant |
High SES female | 10,467 | 10.77 | 10,412 | 10.79 | -55 | 0.02 | Dominant |